Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma.

MLA

Laschinsky, Christina, et al. “Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 64, no. 12, Dec. 2023, pp. 1865–68. EBSCOhost, https://doi.org/10.2967/jnumed.123.266044.

APA

Laschinsky, C., Theurer, S., Herold, T., Rawitzer, J., Weber, F., Herrmann, K., Brandenburg, T., Führer-Sakel, D., Fendler, W. P., & Weber, M. (2023). Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 64(12), 1865–1868. https://doi.org/10.2967/jnumed.123.266044

Chicago

Laschinsky, Christina, Sarah Theurer, Thomas Herold, Josefine Rawitzer, Frank Weber, Ken Herrmann, Tim Brandenburg, Dagmar Führer-Sakel, Wolfgang P Fendler, and Manuel Weber. 2023. “Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 64 (12): 1865–68. doi:10.2967/jnumed.123.266044.